What is Medtronic's current acquisition strategy?

Medtronic is focusing on tuck-in acquisitions, particularly in cardiology and neuroscience, to expand its portfolio and acquire enabling technologies.

How is Medtronic preparing to accelerate deal-making?

Medtronic has established a new committee at the board level to expedite the process of evaluating and executing acquisition deals.

What is Medtronic's financial capacity for mergers and acquisitions?

Medtronic's strong balance sheet provides significant financial flexibility to pursue a substantial number of acquisition transactions without financial strain.

Home / Business and Economy / Medtronic Signals Major Acquisition Push

Medtronic Signals Major Acquisition Push

13 Jan

•

Summary

Medtronic has significant funds for acquisitions.
Focus on cardiology and neuroscience expansion.
New board committee aims to expedite deal-making.

Medtronic Signals Major Acquisition Push

Medtronic is actively seeking to expand its medical device portfolio through significant acquisitions, leveraging its robust financial position. Executives stated at a major industry conference that the company has substantial resources available for merger and acquisition activities. This marks a renewed focus on external growth following several years of operational improvements and divestitures of non-core assets.

The company is prioritizing tuck-in deals, with a particular interest in cardiology and neuroscience sectors. Medtronic aims to acquire companies with early-stage or near-market products that can complement its existing R&D efforts. Deals are expected to be in the low- to mid-single-digit billions of dollars, with a new board committee formed to streamline the acquisition process and increase deal velocity.

This strategic push for acquisitions is supported by a strong balance sheet, providing the flexibility to execute a meaningful number of transactions without financial strain. Medtronic's commitment to M&A signals a confidence in its capacity to enhance its offerings and market presence through targeted investments, while its dividend policy remains unchanged.